Türkiye vs Yemen: Amphetamine use disorder death rate
Türkiye
0.02 deaths per 100,000 people
in 2021
Yemen
0.02 deaths per 100,000 people
in 2021
Türkiye rank
78th
Yemen rank
78th
Amphetamine use disorder death rate over time
- Türkiye
- Yemen
How they compare
Türkiye currently reports 0.02 deaths per 100,000 people against 0.02 deaths per 100,000 people in Yemen, a difference of 0 deaths per 100,000 people.
Across all 22 years both countries report, Yemen has been ahead every year.
Türkiye ranks 78th and Yemen ranks 78th of 194 countries.
Yemen has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Türkiye | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.01 deaths per 100,000 people | 0.017 deaths per 100,000 people | 0.007 deaths per 100,000 people | Yemen |
| 2010s | 0.019 deaths per 100,000 people | 0.02 deaths per 100,000 people | 0.001 deaths per 100,000 people | Yemen |
| 2020s | 0.02 deaths per 100,000 people | 0.02 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder death rate, Türkiye or Yemen?
- Türkiye, at 0.02 deaths per 100,000 people against 0.02 deaths per 100,000 people in Yemen as of 2021.
- What is the difference in amphetamine use disorder death rate between Türkiye and Yemen?
- 0 deaths per 100,000 people, with Türkiye ahead.
- How many years of comparable data are there for Türkiye and Yemen?
- 22 years are reported by both, from 2000 to 2021.
- How do Türkiye and Yemen rank globally for amphetamine use disorder death rate?
- Türkiye ranks 78th and Yemen ranks 78th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in both sexes, per 100,000 people.